N-methyl-D-aspartate receptor - nitric oxide synthase pathway in the cortex of nogo-A-deficient rats in relation to brain laterality and schizophrenia

Frontiers in Behavioral Neuroscience

Volumn , Issue JUL, 2013, Pages

  Krištofiková, Zdena ^a   Vrajová, Monika ^a   Šírová, Jana ^a   Valeš, Karel ^b   Petrásek, Tomáš ^b   Schönig, Kai ^c   Tews, Björn ^d   Schwab, Martin ^e   Bartsch, Dusan ^c   Stuchlík, Aleš ^b   Řípová, Daniela ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Ageing; Animal model of schizophrenia; Brain laterality; Cortex; Myelin associated protein

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NEURONAL NITRIC OXIDE SYNTHASE; PROTEIN NOGO A;

AGE DISTRIBUTION; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FRONTAL CORTEX; HEMISPHERIC DOMINANCE; LEFT HEMISPHERE; MALE; NEUROPATHOLOGY; NONHUMAN; PROTEIN EXPRESSION; RAT; RIGHT HEMISPHERE; SCHIZOPHRENIA;

EID: 84879938625     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2013.00090     Document Type: Article

References (39)

1. Budel, S., Padukkavidana, T., Liu, B.P., Feng, Z., Hu, F., Johnson, S., Lauren, J., Park, J.H., McGee, A.W., Liao, J., Stillman, A., Kim, J.E., Yang, B.Z., Sodi, S., Gelernter, J., Zhao, H., Hisama, F., Arnsten, A.F.T., Strittmatter, S.M. (2008). Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J. Neurosci. 28, 13161-13172.
2. Clinton, S.M., Haroutunian, V., Meador-Woodruff, J.H. (2006). Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia. J. Neurochem. 98, 1114-1125.
3. Clinton, S.M., Meador-Woodruff, J.H. (2004). Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder. Neuropharmacology 29, 1353-1362.
4. Connelly, L., Madhani, M., Hobbs, A.J.(2005). Resistance to endotoxic shock in endothelial nitric-oxide synthase (eNOS) knock-out mice. J. Biol. Chem. 280, 10040-10046.
5. Coon, H., Myles-Worsley, M., Tiobech, J., Hoff, M., Rosenthal, J., Bennett, P., Reimherr, F., Wender, P., Dale, P., Polloi, A., Byerley, W. (1998). Evidence for a chromosome 2p13-14 schizophrenia susceptibility locus in families from Palau, Micronesia. Mol. Psych. 3, 521-527.
6. Davis, K.L., Stewart, D.G., Friedman, J.I., Buchsbaum, M., Harvey, P.D., Hof, P.R., Buxbaum, J., Haroutunian, V. (2003). White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch. Gen. Psychiatry 60, 443-456.
7. Dodd, D.A., Niederoest, B., Bloechlinger, S., Dupuis, L., Leoffler, J.P., Schwab, M.E., (2005). Nogo-A, -B, and -C are found on the cell surface and interact together in many different cell types. J. Biol. Chem. 280, 12494-12502.
8. Gao, X.M., Sakai, K., Roberts, R.C., Conley, R.R., Dean, B., Tamminga, C.A. (2000). Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am. J. Psychiatry 157, 1141-1149.
9. Gil, V., Nicolas, O., Mingorance, A., Ureña, J.M., Tang, B.L., Hirata, T., Sáez-Valero, J., Ferrer, I., Soriano, E., del Río, J.A. (2006). Nogo-A expression in the human hippocampus in normal aging and in Alzheimer disease. J. Neuropathol. Exp. Neurol. 65, 433-444.
10. Hsu, R., Woodroffe, A., Lai, W.S., Cook, M.N., Mukai, J., Dunning, J.P., Swanson, D.J., Roos, J.L., Abecasis, G.R., Karayiorgou, M., Gogos, J.A. (2007). Nogo receptor 1 (RTN4R) as a candidate gene for schizophrenia: analysis using human and mouse genetic approaches. PLoS ONE 2: 1234. doi: 10.1371/journal.pone.0001234.
11. Jitoku, D., Hattori, E., Iwayama, Y., Yamada, K., Toyota, T., Kikuchi, M., Maekawa, M., Nishikawa, T., Yoshikawa, T. (2011). Association study of Nogo-related genes with schizophrenia in a Japanese case-control sample. Am. J. Med. Genet. Part B 156, 581-592.
12. Kamida, T., Takeda, Y., Fujiki, M., Abe, T., Abe, E., Kobayashi, H. (2007). Nitric oxide synthase and NMDA receptor expressions in cavernoma tissues with epileptogenesis. Acta Neurol. Scand. 116, 368-373.
13. Kawakami, R., Shinohara, Y., Kato, Y., Sugiyama, H., Shigemoto, R., Ito, I. (2003). Asymmetrical allocation of NMDA receptor ε2 subunits in hippocampal circuitry. Science 300, 990-994.
14. 2O PET study. Am. J. Psychiatry 160, 919-923.
15. Kirpatrick, B., Messias, E., Harvey, P.D., Fernandez-Egea, E., Bowie, C.R. (2008). Is schizophrenia a syndrome of accelerated aging? Schizophr. Bull. 34, 1024-1032.
16. Krištofiková, Z., Kozmiková, I., Hovorková, P., Říčný, J., Zach, P., Majer, E., Klaschka, J., Řípová, D. (2008). Lateralization of hippocampal nitric oxide mediator system in people with Alzheimer disease, multi-infarct dementia and schizophrenia. Neurochem. Int. 53, 118-125.
17. Krištofiková, Z., Říčný, J., Ort, M., Řípová, D. (2010). Aging and lateralization of the rat brain on a biochemical level. Neurochem Res 35, 1138-1146.
18. Krištofiková, Z., Šťastný, F., Bubeníková, V., Druga, R., Klaschka, J., Španiel, F. (2004). Ageand sex dependent laterality of rat hippocampal cholinergic system in relation to animal models of neurodevelopmental and neurodegenerative disorders. Neurochem. Res. 29, 671-680.
19. Kubota, M., Miyata, J., Yoshida, H., Hirao, K., Fujiwara, H., Kawada, R., Fujimoto, S., Tanaka, Y., Sasamoto, A., Sawamoto, N., Fukuyama, H., Murai, T. (2011). Age-related cortical thinning in schizophrenia. Schizophr. Res. 125, 21-29.
20. Li, D., He, L. (2007). Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: a HuGE review and meta-analysis. Genet. Med. 9, 4-8.
21. Magnusson, K.R., Nelson, S.E., Young, A.B. (2002). Age-related changes in the protein expression of subunits of the NMDA receptor. Brain Res. Mol. Brain Res. 99, 40-45.
22. Mathis, C., Schröter, A., Thallmair, M., Schwab, M.E. (2010). Nogo-A regulates neural precursor migration in the embryonic mouse cortex. Cereb. Cortex 20, 2380-2390.
23. Novak, G., Kim, D., Seeman, P., Tallerico, T. (2002). Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert. Brain Res. Mol. Brain Res. 107, 183-189.
24. Novak, G., Tallerico, T. (2006). Nogo A, B and C expression in schizophrenia, depression and bipolar frontal cortex, and correlation of Nogo expression with CAA/TATC polymorphism in 3́-UTR. Brain Res. 1120, 161-171.
25. Nudmamud-Thanoi, S., Reynolds, G.P. (2004). The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders. Neurosci. Lett. 372, 173-177.
26. Ocklenburg, S., Arning, L., Hahn, C., Gerding, W.M., Epplen, J.T., Güntürkün, O., Beste, C. (2011). Variation in the NMDA receptor 2B subunit gene GRIN2B is associated with differential language lateralization. Behav. Brain Res. 225, 284-289.
27. Rapoport, J.L., Addington, A.M., Frangou, S., Psych M.R.C. (2005). The neurodevelopmental model of schizophrenia: update 2005. Mol. Psychiatry 10, 434-449.
28. Shaw, S.H., Kelly, M., Smith, A.B., Shields, G., Hopkins, P.J., Loftus, J., Laval, S.H., Vita, A., De Hert, M., Cardon, L.R., Crow, T.J., Sherrington, R., DeLisi, L.E. (1998). A genome-wide search for schizophrenia susceptibility genes. Am. J. Med. Genet. 81, 364-376.
29. Simonen, M., Pedersen, V., Weinmann, O., Schnell, L., Buss, A., Ledermann, B., Christ, F., Sansig, G., van der Putten, H., Schwab, M.E. (2003). Systemic deletion of the myelinassociated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 38, 201-211.
30. Sinibaldi, L., De Luca, A., Bellacchio, E., Conti, E., Pasini, A., Paloscia, C., Spalletta, G., Caltagirone, C., Pizzuti, A., Dallapiccola, B. (2004). Mutations of the Nogo-66 receptor (RTN4R) gene in schizophrenia. Hum. Mutat. 24, 534-535.
31. Tan, E.C., Chong, S.A., Wang, H., Lim, E.C.P., Teo, Y.Y. (2005). Gender-specific association of insertion/deletion polymorphisms in the nogo gene and chronic schizophrenia. Mol. Brain Res. 139, 212-216.
32. Tang, B., Chang, W., Lanigan, C.M., Dean, B., Sutcliffe, J.G., Thomas, E.A. (2009). Normal human aging and early-stage schizophrenia share common molecular profiles. Aging Cell. 8, 339-342.
33. Tews, B., Schönig, K., Arzt, M.E., Clementi, S., Rioult-Pedotti, M.S., Zemmar, A., Berger, S., Schneider, M., Weinmann, O., Kasper, H., Schwab, M.E., Bartsch, D. (2013). Synthetic miRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of plasticity, learning and memory. Proc. Natl. Acad. Sci. USA 110, 6583-6588.
34. Toga, A.W., Thompson, P.M. (2003). Mapping brain asymmetry. Nat. Neurosci. 4, 37-48.
35. Turnock-Jones, J.J., Jennings, C.A., Robbins, M.J., Cluderay, J.E., Cilia, J., Reid, J.L., Taylor, A., Jones, D.N., Emson, P.C., Southam, E. (2009). Increased expression of the NR2A NMDA receptor subunit in the prefrontal cortex of rats reared in isolation. Synapse 63, 836-846.
36. Vrajová, M., Šťastný, F., Horáček, J., Lochman, J., Šerý, O., Peková, S., Klaschka, J., Höschl, C. (2010). Expression of the hippocampal receptor GluN1 subunit and its splicing isoforms in schizophrenia: postmortem study. Neurochem. Res. 35, 994-1002.
37. Willi, R., Schwab, M.E. (2013). Nogo and Nogo receptor: relevance to schizophrenia? Neurobiol. Dis. 54, 150-157.
38. Willi, R., Weinmann, O., Winter, C., Klein, J., Sohr, R., Schnell, L., Yee, B.K., Feldon, J., Schwab, M.E. (2010). Constitutive genetic deletion of the growth regulator Nogo-A induces schizophrenia-related endophenotypes. J. Neurosci. 30, 556-567.
39. Woo, T.U.W., Walsh, J.P., Benes, F.M. (2004). Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 61, 649-657.